Metabolite detection is crucial to doc drug use in medical and forensic settings, and phase I metabolites of isotonitazene and metonitazene have already been determined in reliable conditions of consumption (Krotulski et al. 2020, 2021). Nevertheless, the main target was on reporting isotonitazene and metonitazene concentrations, and phase II metab

four-FA reacts with reagent tests to present a semi-exceptional array of colours which may be accustomed to help its identification. Final hues made by reagent examsCritical head aches after coming down from substantial doses have already been claimed. On the other hand, several buyers report a lack of "comedown" or "crash", in its place noting a g